Page last updated: 2024-11-04

terfenadine and Extravascular Hemolysis

terfenadine has been researched along with Extravascular Hemolysis in 1 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Research Excerpts

ExcerptRelevanceReference
"A 48 hours exposure of human erythrocytes to Terfenadine (≥ 5 µM) significantly increased the percentage of annexin-V-binding cells and triggered hemolysis without significantly modifying the average forward scatter."3.83Stimulating Effect of Terfenadine on Erythrocyte Cell Membrane Scrambling. ( Al Mamun Bhuyan, A; Castagna, M; Lang, F; Signoretto, E, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Signoretto, E1
Castagna, M1
Al Mamun Bhuyan, A1
Lang, F1

Other Studies

1 other study available for terfenadine and Extravascular Hemolysis

ArticleYear
Stimulating Effect of Terfenadine on Erythrocyte Cell Membrane Scrambling.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 38, Issue:4

    Topics: Calcium; Calcium Ionophores; Ceramides; Eryptosis; Erythrocyte Membrane; Erythrocytes; Flow Cytometr

2016